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EXPERIMENTAL production of malignant tumours by nickel and its compounds
has been previously reported in different animal species (Hueper, 1952, 1955, 1958).
It was recently demonstrated that a single instramuscular injection of nickel
sulphide is capable of producing a high incidence of rhabdomyosarcomas in rats
(Gilman, 1962). The carcinogenicity of this metallic salt seems rather selective
for striated muscles, but not specific. Malignant muscle tumours have also been
observed in animals injected with cobalt and chromium compounds (Gilman and
Ruckerbauer, 1962; Heath, 1956, 1960; Hueper and Payne, 1959).
That rhabdomyosarcoma can be induced in laboratory animals is ofparamount
interest, because of its high malignancy and ability to produce extensive meta-
stases, a finding uncommon in experimental carcinogenesis with chemical agents.
Animal studies also provide some additional criteria for diagnosis of this undif-
ferentiated tumour in man. The present paper deals with experiments on the
effect of methandrostenolone, an anabolic and myotrophic steroid, on the induc-
tion of rhabdomyosarcomas by nickel sulphide in rats and the growth of such
tumours when transplanted into animals of the same strain.
MATERIALS AND METHODS
The two experimental series were carried out in young female Sprague Dawley
rats weighing 100-115 g., divided into groups and treated as indicated in Tables
I, II and III. The animals were maintained on Purina Laboratory Chow and tap
water, ad libitum.
Experiment No. 1.-In this first series, both groups of rats were injected on
the first day with 0.1 ml. of a 10 per cent aqueous suspension of nickel sulphide
(kindly supplied by Doctor J. P. W. Gilman from the Ontario Veterinary College,
Canada) to which 2000 units ofpenicillin G had been added; injections were given
in the right gastrocnemius. To ascertain that the nickel powder was always
administered at the same site, a 20 gauge 3 in. long needle attached to a tuber-
culin syringe was introduced at the junction of the Achilles tendon and the
muscle, and the injection substance was expelled 3 in. from the point of entry;
treatment with methandrostenolone (kindly supplied by Ciba Company, Montreal)
began on the same day. The steroid was injected subcutaneously as a micro-
crystal suspension at the daily dose of 0 5 mg. in 0-2- ml. of saline. Animals
were under observation for a period of 217 days. Each week, the legs were
examined by palpation in order to detect development of the tumour in the early
stages and to follow its progression.682GAETAN JASMIN
At autopsy, a careful dissection was made in order to weigh the primary
tumour and to evaluate the importance and extent of metastases. All animals
were thoroughly examined in this manner whether they died spontaneously or
were killed with chloroform upon completion of the experiment. Tissues were
fixed in Susa solution for subsequent staining with haemalum-phloxine-saffron
and Masson's trichrome.
Experiment No. 2.-Using one of the tumours previously induced in the con-
trol animals, transplantation was carried out after two successive passages in rats
of the same strain. On subcutaneous passage in tissue slices, the tumour was
found to grow sufficiently rapidly for further transplantation in less than 15 days,
keeping its original histological characters but without formation of necrotic
tissue. Transplantation was made using a cellular suspension prepared by
crushing 2 g. offresh tissue in 10 ml. ofphysiological saline. The integrity ofthe
cells was found to be well preserved when examined under the microscope. The
suspension was injected under sterile conditions in a volume of 0-3 ml. under-
neath the skin of the central lumbar region. Methandrostenolone, as in the
previous experiment, was injected in areas remote from the site of implantation
at a daily dose of 0*5 mg. The animals were killed with chloroform on the 45th
day and the tumours were dissected and fixed in Susa solution for subsequent
weighing and histological studies.
RESULTS
Observations arising from the first experiment are summarized in Tables I and
II. There was little or no local reaction at the site of injection until the 137th
TABLE I.-Action ofMethandrostenolone on Tumour Development at
Site ofInjection ofNickel Sulphide
Overall
Time of average Average Survivors
Number of appearance of time of progression after
Number rats with 1st tumour appearance time* 217 days
Treatment of rats tumours (days) (days) (days) observation
Nickel sulphide . 15 5 149 176-4±10-0 29-4+6-2 13
(P=0.05) (P<O0 05)
Nickel sulphide + 10 10 137 157±4-1 46-2±3*7 5
methandrostenolone
* Average time between appearance of 1st tumour and death.
day, when the first tumour became apparent in a methandrostenolone-treated rat.
Twelve days later, 1 animal from the control group also exhibited a palpable
tumour. As the experiment progressed, the difference between the two groups
became more obvious, especially with regard to the frequency of neoplasm. By
the end of the experiment, only 5 out of 15 control animals had histologically
demonstrable tumours, while none ofthe steroid-treated rats escaped canceration
by nickel sulphide. In the untreated controls, in addition to the lower frequency
of the tumours the average time of appearance was 19 days later than in the
treated animals. This delay shortened the observation period of progression
and the tumours being, therefore, relatively smaller in volume and weight- by
the end of the experiment caused less mortality than in the treated animals.
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When separated from the surrounding skin and adherent-muscle layers, the
tumours were seen to be of firm consistency and greyish in colour; their size
varied between 1 and 5 cm. The larger ones usually invaded the entire thickness
of the abdominal muscle, propagating in the direction of the inguinal region and
often penetrating into the pelvis. Upon sectioning, nickel deposits were apparent
within fibrous tissue, being centrally located (Fig. 2); this area was surrounded
by a more greyish tissue that appeared either as a uniform layer or as separate
nodules, some of which contained necrotic tissue. As a rule, metastases spread
along the aortic lymph glands, which were markedly hypertrophied and whitish
in colour. Only 2 out of the 5 tumour-bearing animals in the control group had
metastases: one of these animals showed a metastatic nodule in the lung paren-
chyma (Table II). In contrast, 8 of the steroid-treated rats had metastases that
extended to the lungs in every case; 2 animals, in addition, showed involvement
ofabdominal organs, suchas the kidney andspleen (Fig. 1), andofthemyocardium.
Histological examination of tumours at the site of origin disclosed a cellular
pattern that varied from the centre to the periphery. The centrally-located
nickel deposits appeared as black dust-like granules surrounded by reticular
giant cells. Necrotic foci were more or less numerous depending upon the rate
oftumour growth; they were formed by acidophilic granular coagulated material,
pyknotic cells, cellular debris, and phagocytes. Very few muscle fibres were
recognizable in these areas, except for some occasional enucleated hyaline fibre
remnants. A common feature was the presence of reticular cells containing a
ferric pigment. The necrotic areas were eventually replaced by a combination
of fibrous tissue and regenerated muscle cells; these were polynucleated and
appeared as elongated or as typical plasmodes. Malignant cells were usually
identified in outer layers exhibiting large atypical nuclei containing several
nucleoli. Some were elongated like spindle cells, but the majority appeared as
giant multinucleated cells with syncytial cytoplasm. There were a few mitotic
figures except in areas rich in connective tissue cells; in areas where the neoplasm
invaded normal muscle fibres the interstitial cellular reaction was almost absent.
Metastases, whether in the aortic lymph nodes, abdominal organs, or lungs,
usually consisted in polynucleated giant cells as previously described, and a num-
ber of more differentiated rhabdomyoblasts that occasionally showed double
striations (Fig. 3).
Table III summarizes results of the second experiment. It was found that
methandrostenolone reduced both the take and the development of the trans-
planted rhabdomyosarcomas. In addition, the tumour nodules in the steroid-
EXPLANATION OF PLATE
FIG. 1.-Gross appearance of Rhabdomyosarcoma of leg and of its metastases in different
organs. Left, tumour nodule in the spleen. Upper centre, neoplastic infiltration of great
omentum. Lower centre, primary tumour in gastrocnemius. Right, large tumour nodule in
left lung.
FIG. 2.-Mid-section of Rhabdomyosarcoma at site of induction. Note black nickel deposits
embedded in fibrotic tissue, which differs from upper neoplastic tissue in being whiter in
colour.
FIG. 3.-Histological aspect of a metastatic nodule in lung. Note typical rhabdomyoblasts,
some of which are elongated and others appear as plasmoidal cells. x 340.
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TABLE III.-Action of Methandrostenolone Upon Development ofa
Transplanted Rhabdomyosarcoma in the Rat
Overall Average
Body average time weight
Number weight ofappearance of tumours
Treatment of rats gain (g.) (days) (g.)
12 . 10 28-5±2-1 426±2-1
(P<03) (P<0*2)
Methandrostenolone . 12 6 . 32 8±3 4 2 66±046
treated animals were more indurated upon sectioning; histological examination
revealed them to be partly fibrotic. The tumours did not spread in either group,
but were adherent to the underlying tissues.
DISCUSSION
There have been several reports pertaining to modification in activity of a
carcinogen by hormone treatment (Bielschowsky, 1961; Bielschowsky and Horn-
ing, 1958; Huggins, Briziarelli and Sutton, 1959; Muhlbock and Van Nie,
1960). This phenomenon is particularly noteworthy at the level oftarget organs
influenced by endocrine secretions (Muihlbock, 1960). It is also well known
that such tissues as the mammary glands may be genetically conditioned to
become neoplastic, if stimulated by a trophic hormone. As far as rhabdomyo-
sarcoma is concerned, we were unable to find any data indicating that the develop-
ment of this tumour is hormone dependent. In surveying 114 cases of human
rhabdomyosarcomas, Stout (1946) noticed a slight preponderance of tumours in
males. On the other hand, a detailed study of spontaneous muscle tumours in
several species of animals did not provide any evidence of sex difference upon the
incidence of such tumours (Blaehser, 1961). Experiments recently carried out
in our laboratory and reported elsewhere (Jasmin, Bajusz and Mongeau, 1963),
revealed that this is also the case in a rat subjected to nickel sulphide.
In the present study, the myotrophic steroid significantly promotes muscle
tumorigenesis as evidenced by a higher incidence of tumours, a reduction of the
latent period, and lengthened progression time. In fact, after 217 days, the
experiment was terminated because all surviving animals of the second group
exhibited respiratory disturbances because of lung metastases. Only one animal
in the control group showed metastases in the lungs.
Methandrostenolone, on the other hand, exerted no significant effect upon
the development of transplanted rhabdomyosarcomas. The steroid even mani-
fested some retarding action as judged by incidence, overall time of appearance,
and weight of the tumours. Thus, it appears that this tumour when it becomes
autonomous and transplantable is no longer responsive to hormonal treatment.
A possible explanation for the reverse action of methandrostenolone is that the
steroid causes an adverse systemic effect upon tumour growth, as previously
reported (Jasmin, Bois and Mongeau, 1960). Consequently, the myotrophic
steroid would act mainly by increasing the susceptibility of muscle tissue at a
critical stage during nickel tumorigenesis, an action that most probably results
from an increase in the metabolic rate of the muscle fibres.
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SUMMARY
Methandrostenolone, an anabolic and myotrophic steroid, was found to
accelerate the carcinogenic activity of a single injection of nickel sulphide into
the gastrocnemius of rats: the incidence of rhabdomyosarcoma was 100 per cent
in steroid-treated rats, in comparison with 33 per cent in untreated controls. A
reverse action was observed when methandrostenolone was administered to
animals transplanted with a previously-induced rhabdomyal tumour.
The action of methandrostenolone consisted mainly in shortening the latent
period ofinduction, resulting in a relatively higher incidence oftumours and more
widespread metastases, for a given period of observation.
This investigation has been supported by a grant from the National Cancer
Institute of Canada.
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